API reference
Levetiracetam
- CAS number
- 102767-28-2
- Molecular formula
- C8H14N2O2
- Molecular weight
- 170.21 g/mol
About this molecule
Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs). Levetiracetam possesses a wide therapeutic index and little-to-no potential to produce, or be subject to, pharmacokinetic interactions - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- InChIKey
- HPHUVLMMVZITSG-LURJTMIESA-N
- SMILES
- CC[C@@H](C(=O)N)N1CCCC1=O
- PubChem CID
- 5284583
Also known as
Levetiracetam · Keppra · (2S)-2-(2-oxopyrrolidin-1-yl)butanamide · Keppra XR · Spritam · UCB-L 059 · ucb L059 · matever
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.